GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+15.7%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$97M
AUM Growth
+$97M
(-11%)
Cap. Flow
-$19.7M
Cap. Flow
% of AUM
-20.34%
Top 10 Holdings %
Top 10 Hldgs %
36.82%
Holding
90
New
29
Increased
10
Reduced
15
Closed
26
Top Buys
| 1 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$3.72M |
| 2 |
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
|
$2.76M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$2.64M |
| 4 |
Merit Medical Systems
MMSI
|
$2.5M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$2.41M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$10.1M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
$3.79M |
| 3 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$3.44M |
| 4 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$3.42M |
| 5 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$3.34M |
Sector Composition
| 1 | Healthcare | 78.03% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$441M
| $4.21M | 2.5% | 110,000 -20,000 | -15% | -$766K |
|
2
Bristol-Myers Squibb
BMY
$96B
| $4.16M | 2.47% | 80,000 -20,000 | -20% | -$1.04M |
|
|
AVDL
3
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.02M | 2.39% | 300,000 +180,000 | +150% | +$2.41M |
|
4
Accuray
ARAY
$157M
| $3.84M | 2.28% | 400,018 -49,982 | -11% | -$480K |
|
|
AMAG
5
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $3.72M | 2.21% | +192,057 | New | +$3.72M |
|
|
CHTP
6
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $3.31M | 1.97% | 600,000 +500,000 | +500% | +$2.76M |
|
|
UNIS
7
DELISTED
Unilife Corporation
UNIS
| $3.26M | 1.93% | 800,000 +450,000 | +129% | +$1.83M |
|
8
Community Health Systems
CYH
$387M
| $3.13M | 1.86% | 80,000 +10,000 | +14% | +$392K |
|
9
Arrowhead Research
ARWR
$3.05B
| $3.04M | 1.8% | 185,000 -90,000 | -33% | -$1.48M |
|
|
TRNX
10
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.76M | 1.64% | 130,000 +30,000 | +30% | +$637K |
|
|
ICPT
11
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.64M | 1.57% | +8,000 | New | +$2.64M |
|
12
Insmed
INSM
$28.8B
| $2.57M | 1.53% | 135,000 -65,000 | -33% | -$1.24M |
|
13
Tandem Diabetes Care
TNDM
$845M
| $2.54M | 1.51% | 115,000 +70,000 | +156% | +$1.55M |
|
|
14
Merit Medical Systems
MMSI
$5.36B
| $2.5M | 1.49% | +175,000 | New | +$2.5M |
|
|
OCRX
15
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.48M | 1.47% | 235,000 +160,000 | +213% | +$1.69M |
|
|
FURX
16
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $2.39M | 1.42% | +27,500 | New | +$2.39M |
|
17
Edwards Lifesciences
EW
$47.8B
| $2.23M | 1.32% | +30,000 | New | +$2.23M |
|
18
Intuitive Surgical
ISRG
$170B
| $2.19M | 1.3% | +5,000 | New | +$2.19M |
|
19
Bruker
BRKR
$5.16B
| $2.05M | 1.22% | 90,000 -25,000 | -22% | -$570K |
|
20
Biogen
BIIB
$19.4B
| $1.98M | 1.18% | 6,471 -9,529 | -60% | -$2.91M |
|
|
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.97M | 1.17% | 130,000 +30,000 | +30% | +$454K |
|
22
Align Technology
ALGN
$10.3B
| $1.81M | 1.08% | +35,000 | New | +$1.81M |
|
|
DYAX
23
DELISTED
DYAX CORPORATION
DYAX
| $1.8M | 1.07% | 200,000 -250,000 | -56% | -$2.25M |
|
|
HSTO
24
DELISTED
Histogen Inc. Common Stock
HSTO
| $1.79M | 1.06% | +219,977 | New | +$1.79M |
|
25
AtriCure
ATRC
$1.84B
| $1.6M | 0.95% | +85,000 | New | +$1.6M |
|